Hepatic FoxO1 Integrates Glucose Utilization and Lipid Synthesis through Regulation of Chrebp O-Glycosylation

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Ido Kitamura, Yukari ^a,d   Sasaki, Tsutomu ^a   Kobayashi, Masaki ^a   Kim, Hye Jin ^a   Lee, Yong Soo ^a   Kikuchi, Osamu ^a   Yokota Hashimoto, Hiromi ^a   Iizuka, Katsumi ^b   Accili, Domenico ^c   Kitamura, Tadahiro ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c College of Physicians and Surgeons of Columbia University ^*  (United States)

^d Fujisawa Shounandai Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; BINDING PROTEIN; CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN; GLUCOSE; INSULIN; MESSENGER RNA; PYRUVATE KINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOLYSIS; LIPOGENESIS; LIVER; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UBIQUITINATION;

ANIMALS; BLOTTING, WESTERN; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE; GLYCOSYLATION; IMMUNOPRECIPITATION; LIVER; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN STABILITY; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 84867290287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047231     Document Type: Article

References (35)

1. Lin HV, Accili D, (2011) Hormonal regulation of hepatic glucose production in health and disease. Cell Metab 14: 9-19.
2. Ferre P, Foufelle F, (2010) Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 12Suppl 2: 83-92.
3. Haeusler RA, Accili D, (2008) The double life of Irs. Cell Metab 8: 7-9.
4. Accili D, Arden KC, (2004) FoxOs at the Crossroads of Cellular Metabolism, Differentiation, and Transformation. Cell 117: 421-426.
5. Shin DJ, Osborne TF, (2009) FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action. J Biol Chem 284: 11110-11120.
6. Uyeda K, Repa JJ, (2006) Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab 4: 107-110.
7. Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, et al. (2001) A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A 98: 9116-9121.
8. Ishii S, Iizuka K, Miller BC, Uyeda K, (2004) Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc Natl Acad Sci U S A 101: 15597-15602.
9. Kabashima T, Kawaguchi T, Wadzinski BE, Uyeda K, (2003) Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci U S A 100: 5107-5112.
10. Kawaguchi T, Takenoshita M, Kabashima T, Uyeda K, (2001) Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci U S A 98: 13710-13715.
11. Haeusler RA, Han S, Accili D, (2010) Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia. J Biol Chem 285: 26861-26868.
12. Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D, (2007) Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab 6: 208-216.
13. Kitamura YI, Kitamura T, Kruse JP, Raum JC, Stein R, et al. (2005) FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab 2: 153-163.
14. Nakae J, Kitamura T, Silver DL, Accili D, (2001) The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108: 1359-1367.
15. Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs WH 3rd, et al(2002) The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110: 1839-1847.
16. Paik JH, Kollipara R, Chu G, Ji H, Xiao Y, et al. (2007) FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128: 309-323.
17. Matsumoto M, Han S, Kitamura T, Accili D, (2006) Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 116: 2464-2472.
18. Nakae J, Kitamura T, Kitamura Y, Biggs WH, Arden KC, et al. (2003) The forkhead transcription factor foxo1 regulates adipocyte differentiation. Dev Cell 4: 119-129.
19. Guinez C, Filhoulaud G, Rayah-Benhamed F, Marmier S, Dubuquoy C, et al. (2011) O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 60: 1399-1413.
20. Horton JD, Goldstein JL, Brown MS, (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131.
21. Brown MS, Goldstein JL, (1999) A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A 96: 11041-11048.
22. Chen G, Liang G, Ou J, Goldstein JL, Brown MS, (2004) Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci U S A 101: 11245-11250.
23. Cha JY, Repa JJ, (2007) The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem 282: 743-751.
24. Bouche C, Serdy S, Kahn CR, Goldfine AB, (2004) The cellular fate of glucose and its relevance in type 2 diabetes. Endocr Rev 25: 807-830.
25. Copeland RJ, Bullen JW, Hart GW, (2008) Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab 295: E17-28.
26. McClain DA, Lubas WA, Cooksey RC, Hazel M, Parker GJ, et al. (2002) Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci U S A 99: 10695-10699.
27. Housley MP, Rodgers JT, Udeshi ND, Kelly TJ, Shabanowitz J, et al. (2008) O-GlcNAc regulates FoxO activation in response to glucose. J Biol Chem 283: 16283-16292.
28. Kuo M, Zilberfarb V, Gangneux N, Christeff N, Issad T, (2008) O-glycosylation of FoxO1 increases its transcriptional activity towards the glucose 6-phosphatase gene. FEBS Lett 582: 829-834.
29. Housley MP, Udeshi ND, Rodgers JT, Shabanowitz J, Puigserver P, et al. (2009) A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose. J Biol Chem 284: 5148-5157.
30. Dentin R, Hedrick S, Xie J, Yates J 3rd, Montminy M, (2008) Hepatic glucose sensing via the CREB coactivator CRTC2. Science 319: 1402-1405.
31. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96: 857-868.
32. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, et al. (1999) Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature. 398: 630-634.
33. Nakae J, Park BC, Accili D, (1999) Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J Biol Chem 274: 15982-15985.
34. Nakae J, Biggs WH, Kitamura T, Cavenee WK, Wright CV, et al. (2002) Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 32: 245-253.
35. Spiriti J, Bogani F, van der Vaart A, Ghirlanda G, (2008) Modulation of protein stability by O-glycosylation in a designed Gc-MAF analog. Biophys Chem 134: 157-167.